Diet in the Management of Acromegaly
NCT05401084 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2024-04-19
Summary
Impact of low carbohydrate and low gluten diet on acromegaly progression, symptoms, complications, and treatment outcomes.
Conditions
Interventions
- OTHER
-
Diet
Macronutrient diet changes.
Sponsors & Collaborators
-
Cedars-Sinai Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-20
- Primary Completion
- 2025-03-01
- Completion
- 2025-03-01
Countries
- United States
Study Locations
More Related Trials
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance
NCT00663000 ·Status: COMPLETED
-
An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
NCT01995734 ·Status: APPROVED_FOR_MARKETING
-
Surgical Versus Medical Treatment of Acromegaly
NCT01000090 ·Status: COMPLETED
-
Treatment Patterns and Treatment Outcomes for Acromegaly
NCT03043586 ·Status: COMPLETED
-
Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
NCT00915954 ·Status: COMPLETED ·Phase: NA
-
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
NCT01568359 ·Status: COMPLETED
-
A Prospective Study of Outcome After Therapy for Acromegaly
NCT01809808 ·Status: COMPLETED
-
IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly
NCT02084095 ·Status: COMPLETED
-
Brain-gut Interaction in Irradiated Patients With Acromegaly
NCT02005978 ·Status: UNKNOWN
-
Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects
NCT01723748 ·Status: COMPLETED ·Phase: NA
-
Prospective Study on Changes in Acromegaly
NCT01612624 ·Status: UNKNOWN
-
Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients
NCT01014793 ·Status: COMPLETED
-
Effects of GH and Lirglutide on AgRP
NCT05681299 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
NCT00225979 ·Status: COMPLETED ·Phase: PHASE3
-
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
NCT00005100 ·Status: UNKNOWN
-
Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
NCT01295060 ·Status: TERMINATED ·Phase: PHASE3
-
Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
NCT02092129 ·Status: UNKNOWN
-
Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
NCT02115906 ·Status: UNKNOWN
-
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
NCT00182091 ·Status: COMPLETED ·Phase: NA
-
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
NCT00921609 ·Status: COMPLETED
-
Open Label Study of Octreotide Implant in Patients With Acromegaly
NCT00913055 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
NCT00447499 ·Status: COMPLETED ·Phase: PHASE3
-
Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
NCT02012127 ·Status: COMPLETED
-
Acromegaly Treatment Quality of Life Study
NCT01732406 ·Status: COMPLETED